Clinical Trials

Study Title:
A Multi-Center Phase Ib Trial Evaluating the Safety and Efficacy of Lacutamab in Patients With Relapse Peripheral T-Cell Lymphoma That Express KIR3DL2

For more information about the trial above please contact the study team:

Principal Investigator, Irl Greenwell, at greenwe@musc.edu, or please call +1 843-792-4759.

Study Coordinator, Christina Paskal, at paskal@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina